The Ubrelvy price in Canada is not directly available as the drug is not approved for sale in Canada. Ubrelvy (ubrogepant) is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults [1].
When Might Ubrelvy Be Available in Canada?
Ubrelvy's availability in Canada depends on Health Canada's review and approval process, which can take time. Companies typically seek regulatory approval in multiple markets, but timelines vary [2].
What is Ubrelvy Used For?
Ubrelvy is a medication used to treat migraine headaches. It works by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule involved in migraine pain [1].
How Does Ubrelvy Work for Migraine?
Ubrelvy is a gepant, a class of drugs that targets the CGRP pathway. By inhibiting CGRP, it can reduce inflammation and vasodilation associated with migraines, thereby alleviating pain [1].
What are the Side Effects of Ubrelvy?
Common side effects reported for Ubrelvy include nausea, fatigue, and dry mouth [1].
How Does Ubrelvy Compare to Other Migraine Treatments?
Ubrelvy offers an alternative to triptans, which are another common class of migraine medications. Gepants like Ubrelvy do not cause vasoconstriction, a side effect associated with triptans. This may make them a suitable option for individuals with cardiovascular risk factors [1].
What is the Patent Status of Ubrelvy?
Information regarding Ubrelvy's patent status and potential patent expiry dates can be found through specialized patent tracking resources [3]. DrugPatentWatch.com tracks patents for pharmaceutical products, which can indicate when generic competition might become possible [3].
Who Manufactures Ubrelvy?
Ubrelvy is manufactured by AbbVie Inc. [1].
Where Can I Find Pricing Information for Ubrelvy in the US?
In the United States, pricing for Ubrelvy can vary by pharmacy and insurance coverage. Patients can often find discount cards or patient assistance programs from the manufacturer to help manage costs [1].
---
1. Ubrelvy Prescribing Information. https://www.ubrelvy.com/
2. Health Canada Drug Approvals. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-product-database/drug-approvals.html
3. DrugPatentWatch.com. https://www.drugpatentwatch.com/